Mohamed Benchekroun | Charles Explorer

The antioxidant additive approach for Alzheimer's disease therapy: New ferulic (Lipoic) acid plus melatonin modified tacrines as Cholinesterases inhibitors, direct antioxidants, and nuclear factor (Erythroid-Derived 2)-like 2 activators

2016 | Publikace bez příslušnosti k fakultě